The dipeptidyl peptidase inhibitor BXCL701 activates innate immunity followed by adaptive immunity on a molecular and cellular level in a mouse model of pancreatic cancer-MedSci.cn

The dipeptidyl peptidase inhibitor BXCL701 activates innate immunity followed by adaptive immunity on a molecular and cellular level in a mouse model of pancreatic cancer

Agarwal, V; MacDougall, J; Trivedi, S; Bhatia, D; Jagga, Z; Banga, H; Healy, D; Adurthi, S; O' Neill, V

CANCER RESEARCH, 2020; 80 (16):

科室
- - 订阅+
  - 更多科室
工具
服务